RESUMO
PURPOSE: Nut-enriched diets are related to improve lipid and inflammatory biomarkers in meta-analyses in the context of primary cardiovascular prevention. However, primary studies on secondary cardiovascular prevention are scarce and controversial. This systematic review and meta-analysis aimed to evaluate the effect of nut supplementation on lipid and inflammatory profiles in individuals with atherosclerotic cardiovascular disease, and the frequency of adverse events. METHODS: Six databases were used for research: PubMed, EMBASE, BVS, Cochrane Library, Web of Science, and ClinicalTrials.gov, until February 2023, with no language restrictions. We performed random-effects meta-analyses to compare nut-enriched diets vs. control diets for pre-post intervention changes. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) system assessed the evidence's certainty. RESULTS: From the 5187 records identified, eight publications containing data referring to five randomized clinical trials involving 439 participants were included in the final analyses. The nuts evaluated were almonds, pecans, Brazil nuts, and mixed nuts, with doses ranging between 5 g and 85 g (median: 30 g/day). The intervention time varied between 6 and 12 weeks. Compared to nut-free diets, nut intake did not have a statistically significant effect on lipid profile biomarkers, except on the atherogenic index (MD: -0.32 [95% CI -0.58 to -0.06], I2 = 0% - moderate certainty of the evidence). Similarly, there was no effect of nuts on inflammatory profile biomarkers. It was not possible to aggregate data on adverse events. CONCLUSIONS: Nut supplementation did not change lipid and inflammatory profiles in the secondary cardiovascular prevention setting.
RESUMO
Objective: To synthesize the evidence on the effectiveness of hospital transition care in the elderly to support decision-making. Method: This rapid systematic review followed the recommendations of the Cochrane Rapid Reviews Methods Group. Studies were selected from the PubMed, EMBASE, Cochrane Library, and Virtual Health Library (BVS) databases using the following criteria: focus on the elderly as population; provision of hospital transition care as intervention; care as usual (non-transition care) as comparator; and effectiveness of the presence vs. absence of transition care as the outcome, with effectiveness defined as improvement in any evaluated parameter. Systematic reviews published in Portuguese, English, or Spanish, with or without meta-analysis, that assessed hospital transition care in elderly individuals were included. Studies lacking a description of the intervention and target population were excluded. Results: Of the 207 identified reviews, 18 were included. The studies were conducted in 21 countries, with 10 studies conducted in Europe and one in Brazil. The effectiveness of care for the elderly was demonstrated through increased adherence to medication regimens, reduced adverse events and medication-related errors, improved functional status, reduced falls, and reduced healthcare costs. Conclusions: Despite the evidence indicating the effectiveness of hospital transition care, further research is needed to develop more robust indicators of clinical improvement and integration into healthcare systems.
Objetivo: Sintetizar la evidencia sobre la eficacia de la atención transitoria prestada a las personas mayores después del alta hospitalaria con el fin de ayudar a los gerentes en la toma de decisiones. Métodos: En esta revisión sistemática rápida se siguieron las recomendaciones del Grupo Cochrane de Métodos de Revisiones Rápidas y se seleccionaron estudios en las bases de datos PubMed, EMBASE, Biblioteca Cochrane y Biblioteca Virtual de Salud. Para la selección de los estudios se consideraron los siguientes criterios: como población, personas mayores; como intervención, la prestación de atención transitoria después del alta hospitalaria; como comparador, la ausencia de atención transitoria después del alta hospitalaria; y como resultado, la eficacia del uso frente a la falta de uso de la atención transitoria, tomando como definición de eficacia la mejora de cualquier parámetro evaluado. Se incluyeron revisiones sistemáticas publicadas en español, inglés o portugués, con o sin metanálisis, en las cuales se evaluara la atención transitoria prestada a personas mayores después del alta hospitalaria y se excluyeron los estudios sin descripción de la intervención o del público destinatario correspondientes. Resultados: Se incluyeron 18 de las 207 revisiones halladas. Los estudios se habían realizado en 21 países (10 estudios en Europa y uno en Brasil). Se demostró la eficacia de la atención prestada a las personas mayores en cuanto a una mayor observancia de los tratamientos farmacológicos, una reducción del número de eventos adversos y errores en el uso de los medicamentos, una mejora del estado funcional de las personas mayores, una disminución de las caídas y un menor costo de la atención. Conclusiones: A pesar de haberse comprobado la eficacia de la atención transitoria, se necesitan nuevas investigaciones para elaborar indicadores más sólidos de la mejora clínica y de la integración en los sistemas de salud.
RESUMO
BACKGROUND: To assess whether use of low-chloride solutions in unselected critically ill or perioperative adult patients for maintenance or resuscitation reduces mortality and renal replacement therapy (RRT) use when compared to high-chloride fluids. METHODS: Systematic review and meta-analysis with random-effects inverse variance model. PubMed, Cochrane library, EMBASE, LILACS, and Web of Science were searched from inception to October 2016. Published and unpublished randomized controlled trials in any language that enrolled critically ill and/or perioperative adult patients and compared a low- to a highchloride solution for volume maintenance or resuscitation. The primary outcomes were mortality and RRT use. We conducted trial sequential analyses and assessed risk of bias of individual trials and the overall quality of evidence. Fifteen trials with 4067 patients, most at low risk of bias, were identified. Of those, only 11 and 10 trials had data on mortality and RRT use, respectively. A total of 3710 patients were included in the mortality analysis and 3724 in the RRT analysis. RESULTS: No statistically significant impact on mortality (odds ratio, 0.90; 95% confidence interval, 0.69-1.17; P = .44; I = 0%) or RRT use (odds ratio, 1.12; 95% confidence interval, 0.80-1.58; P = .52; I = 0%) was found. Overall quality of evidence was low for both primary outcomes. Trial sequential analyses highlighted that the sample size needed was much larger than that available for properly powered outcome assessment. CONCLUSIONS: The current evidence on low- versus high-chloride solutions for unselected critically ill or perioperative adult patients demonstrates no benefit, but suffers from considerable imprecision. We noted a limited exposure volume for study fluids and a relatively low risk of the populations in each study. Together with the relatively small pooled sample size, these data leave us underpowered to detect potentially important differences. Results from well-conducted, adequately powered randomized controlled trials examining sufficiently large fluid exposure are necessary.
Assuntos
Estado Terminal/terapia , Assistência Perioperatória/métodos , Cloreto de Sódio/administração & dosagem , Cloreto de Sódio/química , Administração Intravenosa , Adulto , Estado Terminal/epidemiologia , Composição de Medicamentos , Humanos , Tempo de Internação/tendências , Assistência Perioperatória/tendências , Soluções Farmacêuticas/administração & dosagem , Soluções Farmacêuticas/química , Desequilíbrio Hidroeletrolítico/epidemiologia , Desequilíbrio Hidroeletrolítico/prevenção & controleRESUMO
CONTEXT: Nut-enriched diets have a positive impact on cardiovascular risk factors, such as body mass, blood pressure, and fasting blood glucose. However, studies in individuals undergoing secondary cardiovascular prevention show controversial results. OBJECTIVE: This systematic review with meta-analysis assessed the effect of nut supplementation on anthropometric, glycemic, and blood pressure indices in patients with atherosclerotic cardiovascular disease, as well as the frequency of adverse events. DATA SOURCES: Six databases were used for the search-PubMed, Cochrane Library, EMBASE, BVS (Biblioteca Virtual da Saude), Web of Science, and ClinicalTrials.gov-until February 2023, with no language restrictions. DATA EXTRACTION: The Cochrane Handbook for Systematic Reviews of Interventions methodology and the PICOS (Population, Intervention, Comparison, Outcome, Setting/design) strategy were used. Seven independent reviewers were involved in data extraction and resolution of disagreements. Certainty of the evidence was evaluated using the GRADE (Grading of Recommendations Assessment, Development and Evaluation) system. DATA ANALYSIS: From 5187 records identified, 6 publications containing data referring to 5 randomized clinical trials (n = 436) were included in the final analyses. The nuts evaluated were almonds, pecans, Brazil nuts, and mixed nuts, with portions that varied between 5 g and 85 g (median: 30 g/day). The intervention period varied between 6 and 12 weeks. The nuts had no effect on fasting glucose and anthropometric indices, although the certainty of the evidence for most of these outcomes was low or very low. They also had no effect on systolic (mean difference [MD]: -1.16 mmHg [95% CI, -5.68 to 3.35], I2 = 0%-moderate certainty of evidence) or diastolic (MD: 0.10 mmHg [95% CI, -2.30 to 2.51], I2 = 0%-high certainty of evidence) blood pressure. It was not possible to aggregate data on adverse events. CONCLUSION: Nut supplementation had no effect on blood pressure, fasting glucose, or anthropometric profile in the context of atherosclerotic cardiovascular disease. SYSTEMATIC REVIEW REGISTRATION: PROSPERO registration no. CRD42020163456.
RESUMO
BACKGROUND & AIMS: This umbrella review of systematic reviews with meta-analysis (SR-MAs) aimed to evaluate the risk of bias and the certainty of the evidence of SR-MAs on the association between obesity and mortality in patients with SARS-CoV-2. METHODS: We conducted a comprehensive literature search until April 22, 2022, in several databases and assessed the risk of bias of SR-MAs according to AMSTAR-2 and the certainty of evidence using the GRADE approach. The degree of overlap between meta-analyses was based on the corrected covered area (CCA) index. The results of each MA [relative risk (RR), hazard ratio (HR), or odds ratio (OR)] were extracted to evaluate the magnitude of the association between obesity and mortality. RESULTS: A total of 24 SR-MAs were eligible, and the association between obesity and mortality was not statistically significant in eight (33.3%) of them, while the OR/HR/RR ranged from 1.14 to 3.52 in the other SR-MAs. The overlap was slight (CCA = 4.82%). The majority of SR-MAs presented critically low quality according to AMSTAR-2 (66.7%), and the certainty of the evidence for most of them (83.4%) was "very low". CONCLUSIONS: Obesity was associated with an increased risk of death in patients with SARS-CoV-2 infection in most SR-MAs; however, a critical appraisal pointed to a high risk of bias, and the certainty of their evidence was not well graded. The dissemination of poor SR-MAs may limit the interpretation of findings, and we should always aspire to trustworthy scientific evidence. PROSPERO: PROSPERO 2021 CRD42021253142.
Assuntos
COVID-19 , SARS-CoV-2 , Humanos , Revisões Sistemáticas como Assunto , Obesidade/complicaçõesRESUMO
INTRODUCTION: Atypical antipsychotics have been studied to treat autism spectrum disorder (ASD). However, like little is known about whether these drugs are effective and safe when compared in controlled and non-controlled settings. This study aims to assess the efficacy and safety of second-generation antipsychotics in ASD in randomised controlled trials (RCT) and observational studies. METHODS AND ANALYSIS: This systematic review will include RCT and prospective cohorts evaluating second-generation antipsychotics in people 5 years and older diagnosed with ASD. Searches will be conducted in Medline, Embase, Cochrane Library, Epistemonikos, Lilacs, CINAHL, PsycINFO, trial registries and grey literature databases without restriction on publication status, year of publication and language. The primary outcomes will be symptoms of aggressive behaviour, quality of life for the individual or their careers, and discontinuation or dropouts/withdrawals of antipsychotics due to adverse events. The secondary outcomes are other not serious adverse events and adherence to pharmacotherapy. Selection, data extraction, and quality assessment will be performed by pairs of reviewers, independently. The Risk of Bias 2 (RoB 2) and Risk of Bias in Non-Randomised Studies of Interventions (ROBINS-I) tools will be used to assess the risk of bias in the included studies. If appropriate, a meta-analysis and network meta-analysis will be conducted to synthesise the results. The overall quality of the evidence for each outcome will be determined by the Recommendation, Assessment, Development and Evaluation approach. ETHICS AND DISSEMINATION: This study will systematically summarise the existing evidence evaluating the use of second-generation antipsychotics for treating ASD, in controlled and uncontrolled studies. The results of this review will be disseminated through peer-reviewed publications and conference presentations. PROSPERO REGISTRATION NUMBER: CRD42022353795.
Assuntos
Antipsicóticos , Transtorno do Espectro Autista , Humanos , Antipsicóticos/efeitos adversos , Transtorno do Espectro Autista/tratamento farmacológico , Viés , Metanálise como Assunto , Estudos Observacionais como Assunto , Ensaios Clínicos Controlados Aleatórios como Assunto , Projetos de Pesquisa , Revisões Sistemáticas como AssuntoRESUMO
BACKGROUND: The management of type 2 diabetes mellitus (T2DM) requires a complex and organized care that includes patient's lifestyle change. Additionally, emotional well-being is an important part of self-management, and it may impair the individual's adherence. Therefore, equipping the patients with the necessary coping and self-care techniques may be an important step in managing diabetes. OBJECTIVE: To evaluate the effect of interventions using established mindfulness-based protocols on glycemic control of individuals with T2DM. METHODS: Data sources: Two electronic databases (PubMed and EMBASE) were searched from inception to December 2019. We limited our search to published studies in English, Spanish and Portuguese languages. STUDY SELECTION: Randomized clinical trials that assessed the effects of mindfulness in individuals with T2DM were selected. DATA EXTRACTION: Two authors independently assessed the risk of bias and extracted data from the included trials. Data were pooled using inverse-variance random-effects meta-analyses. The quality of evidence was assessed using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) system. RESULTS: Four randomized trials were included. There were no differences in blood glucose change (mean difference between groups (MD) -0.73mg/dl; 95% CI, -10.49; 9.02; I2 =0%; very low quality of evidence) or glycated hemoglobin (MD 0.05%; 95%CI -0.22 to 0.32; I2 =29%; very low quality of evidence). CONCLUSION: Although the quality of current evidence is very low, our findings suggest that established protocols involving mindfulness have no effect on blood glucose or glycated hemoglobin in individuals with T2DM. Indeed, large-scale trials are needed to evaluate the contribution of mindfulness to glycemic control in clinical practice. PROSPERO Registration ID: RD42020161940.
Assuntos
Diabetes Mellitus Tipo 2 , Atenção Plena , Ensaios Clínicos Controlados Aleatórios como Assunto , Autogestão , Glicemia , Diabetes Mellitus Tipo 2/terapia , Hemoglobinas Glicadas , HumanosRESUMO
BACKGROUND: Antimicrobial resistance is currently considered the main risk to global health. A variety of microbial species have been isolated from endodontic and periodontal infections. However, clinical endodontic and periodontics bacterial isolates have not been sufficiently characterized with regard to their capacity for antibiotic resistance. We aim to assess the existing evidence to estimate the prevalence of the main antimicrobial resistance and multidrug resistant organisms in endodontics and periodontics and to describe their geographic distribution in Latin America. METHODS: All types of designs and will be restricted to Latin American studies will be included in this systematic review. MEDLINE, Embase, CINAHL, BVS (LILACS, BBO - bvsalud.org), IBECS (bases.bireme.br), Google Scholar, Cochrane Central Register of Controlled Trials, and Web of Science databases will be searched from 2013 to December 31, 2018 for all types of study designs that report microbial infection in endodontics and periodontics and their resistance and that define the microbiological methods used to identify microorganisms. The selection of articles for inclusion will be performed by 2 reviewers using predefined eligibility criteria. The Cochrane and ROBINS-I risk of bias assessment tools will be used to assess the methodological quality of randomized control trials. The Newcastle-Ottawa scale will be used to assess the quality of methodology in observational studies. The overall quality of evidence will be assessed using Grading of Recommendations Assessment, Development and Evaluation (GRADE) using the same principles and domains applied in the quality assessment of prognostic studies. The heterogeneity of the findings will be assessed using both the χ test and the I statistic. Sensitivity analysis will be performed by subgroup analyses and meta-regression to investigate the effect of study-level characteristics, such as age, gender, and methodological quality score, whenever possible. Publication bias across studies will be evaluated by visual inspection of the funnel plots and Begg's test for the results covered in 10 or more studies. RESULTS: The evidence derived by this study will inform best practices for patients with endodontic and periodontal problems receiving antimicrobial agents. CONCLUSION: Successful completion will significantly impact clinical practice and contribute to improved prescribing competency. PROTOCOL REGISTRATION: PROSPERO-CRD42018077810.
Assuntos
Anti-Infecciosos/farmacologia , Anti-Infecciosos/uso terapêutico , Infecções Bacterianas/tratamento farmacológico , Resistência Microbiana a Medicamentos , Doenças Periodontais/tratamento farmacológico , Técnicas Bacteriológicas , Humanos , América Latina/epidemiologia , Periodontite Periapical/tratamento farmacológico , Projetos de PesquisaRESUMO
[RESUMO]. Objetivo. Sintetizar as evidências de efetividade dos cuidados de transição em idosos após alta hospitalar para subsidiar gestores para a tomada de decisão. Métodos. Esta revisão sistemática rápida seguiu as recomendações do Cochrane Rapid Reviews Methods Group e selecionou estudos nas bases de dados Pubmed, EMBASE, Cochrane Library e Biblioteca Virtual em Saúde. Para selecionar os estudos, foram considerados: como população, indivíduos idosos; como intervenção, a realização de cuidados de transição após alta hospitalar; como comparador, a ausência de cuidado de transição após alta hospitalar; e como desfecho, a efetividade da presença vs. ausência de cuidados de transição, sendo efetividade definida como a melhora em qualquer parâmetro avaliado. Foram incluídas revisões sistemáticas publicadas em português, inglês ou espanhol, com ou sem metanálise, que avaliaram os cuidados de transição para idosos após alta hospitalar; e excluídos estudos sem descrição da intervenção e do público-alvo. Resultados. Das 207 revisões identificadas, 18 foram incluídas. Os estudos foram realizados em 21 países, sendo 10 estudos desenvolvidos na Europa e um no Brasil. A efetividade dos cuidados com os idosos foi demonstrada por maior adesão aos tratamentos medicamentosos, redução dos eventos adversos e dos erros relacionados aos medicamentos, melhora do estado funcional nos idosos, redução de quedas e redução dos custos no cuidado. Conclusões. Apesar das evidências que indicam a efetividade dos cuidados de transição, novas pesquisas são necessárias para desenvolver indicadores mais robustos de melhora clínica e integração aos sistemas de saúde.
[ABSTRACT]. Objective. To synthesize the evidence on the effectiveness of hospital transition care in the elderly to support decision-making. Method. This rapid systematic review followed the recommendations of the Cochrane Rapid Reviews Methods Group. Studies were selected from the PubMed, EMBASE, Cochrane Library, and Virtual Health Library (BVS) databases using the following criteria: focus on the elderly as population; provision of hospital transition care as intervention; care as usual (non-transition care) as comparator; and effectiveness of the presence vs. absence of transition care as the outcome, with effectiveness defined as improvement in any evaluated parameter. Systematic reviews published in Portuguese, English, or Spanish, with or without meta-analysis, that assessed hospital transition care in elderly individuals were included. Studies lacking a description of the intervention and target population were excluded. Results. Of the 207 identified reviews, 18 were included. The studies were conducted in 21 countries, with 10 studies conducted in Europe and one in Brazil. The effectiveness of care for the elderly was demonstrated through increased adherence to medication regimens, reduced adverse events and medication-related errors, improved functional status, reduced falls, and reduced healthcare costs. Conclusions. Despite the evidence indicating the effectiveness of hospital transition care, further research is needed to develop more robust indicators of clinical improvement and integration into healthcare systems.
[RESUMEN]. Objetivo. Sintetizar la evidencia sobre la eficacia de la atención transitoria prestada a las personas mayores después del alta hospitalaria con el fin de ayudar a los gerentes en la toma de decisiones. Métodos. En esta revisión sistemática rápida se siguieron las recomendaciones del Grupo Cochrane de Métodos de Revisiones Rápidas y se seleccionaron estudios en las bases de datos PubMed, EMBASE, Biblioteca Cochrane y Biblioteca Virtual de Salud. Para la selección de los estudios se consideraron los siguientes criterios: como población, personas mayores; como intervención, la prestación de atención transitoria después del alta hospitalaria; como comparador, la ausencia de atención transitoria después del alta hospitalaria; y como resultado, la eficacia del uso frente a la falta de uso de la atención transitoria, tomando como definición de eficacia la mejora de cualquier parámetro evaluado. Se incluyeron revisiones sistemáticas publicadas en español, inglés o portugués, con o sin metanálisis, en las cuales se evaluara la atención transitoria prestada a personas mayores después del alta hospitalaria y se excluyeron los estudios sin descripción de la interven- ción o del público destinatario correspondientes. Resultados. Se incluyeron 18 de las 207 revisiones halladas. Los estudios se habían realizado en 21 países (10 estudios en Europa y uno en Brasil). Se demostró la eficacia de la atención prestada a las personas mayo- res en cuanto a una mayor observancia de los tratamientos farmacológicos, una reducción del número de eventos adversos y errores en el uso de los medicamentos, una mejora del estado funcional de las personas mayores, una disminución de las caídas y un menor costo de la atención. Conclusiones. A pesar de haberse comprobado la eficacia de la atención transitoria, se necesitan nuevas investigaciones para elaborar indicadores más sólidos de la mejora clínica y de la integración en los sistemas de salud.
Assuntos
Cuidado Transicional , Serviços de Saúde para Idosos , Política de Saúde , Efetividade , Cuidado Transicional , Serviços de Saúde para Idosos , Política de Saúde , Efetividade , Cuidado Transicional , Serviços de Saúde para Idosos , Política de Saúde , EfetividadeRESUMO
RESUMO Objetivo. Sintetizar as evidências de efetividade dos cuidados de transição em idosos após alta hospitalar para subsidiar gestores para a tomada de decisão. Métodos. Esta revisão sistemática rápida seguiu as recomendações do Cochrane Rapid Reviews Methods Group e selecionou estudos nas bases de dados Pubmed, EMBASE, Cochrane Library e Biblioteca Virtual em Saúde. Para selecionar os estudos, foram considerados: como população, indivíduos idosos; como intervenção, a realização de cuidados de transição após alta hospitalar; como comparador, a ausência de cuidado de transição após alta hospitalar; e como desfecho, a efetividade da presença vs. ausência de cuidados de transição, sendo efetividade definida como a melhora em qualquer parâmetro avaliado. Foram incluídas revisões sistemáticas publicadas em português, inglês ou espanhol, com ou sem metanálise, que avaliaram os cuidados de transição para idosos após alta hospitalar; e excluídos estudos sem descrição da intervenção e do público-alvo. Resultados. Das 207 revisões identificadas, 18 foram incluídas. Os estudos foram realizados em 21 países, sendo 10 estudos desenvolvidos na Europa e um no Brasil. A efetividade dos cuidados com os idosos foi demonstrada por maior adesão aos tratamentos medicamentosos, redução dos eventos adversos e dos erros relacionados aos medicamentos, melhora do estado funcional nos idosos, redução de quedas e redução dos custos no cuidado. Conclusões. Apesar das evidências que indicam a efetividade dos cuidados de transição, novas pesquisas são necessárias para desenvolver indicadores mais robustos de melhora clínica e integração aos sistemas de saúde.
ABSTRACT Objective. To synthesize the evidence on the effectiveness of hospital transition care in the elderly to support decision-making. Method. This rapid systematic review followed the recommendations of the Cochrane Rapid Reviews Methods Group. Studies were selected from the PubMed, EMBASE, Cochrane Library, and Virtual Health Library (BVS) databases using the following criteria: focus on the elderly as population; provision of hospital transition care as intervention; care as usual (non-transition care) as comparator; and effectiveness of the presence vs. absence of transition care as the outcome, with effectiveness defined as improvement in any evaluated parameter. Systematic reviews published in Portuguese, English, or Spanish, with or without meta-analysis, that assessed hospital transition care in elderly individuals were included. Studies lacking a description of the intervention and target population were excluded. Results. Of the 207 identified reviews, 18 were included. The studies were conducted in 21 countries, with 10 studies conducted in Europe and one in Brazil. The effectiveness of care for the elderly was demonstrated through increased adherence to medication regimens, reduced adverse events and medication-related errors, improved functional status, reduced falls, and reduced healthcare costs. Conclusions. Despite the evidence indicating the effectiveness of hospital transition care, further research is needed to develop more robust indicators of clinical improvement and integration into healthcare systems.
RESUMEN Objetivo. Sintetizar la evidencia sobre la eficacia de la atención transitoria prestada a las personas mayores después del alta hospitalaria con el fin de ayudar a los gerentes en la toma de decisiones. Métodos. En esta revisión sistemática rápida se siguieron las recomendaciones del Grupo Cochrane de Métodos de Revisiones Rápidas y se seleccionaron estudios en las bases de datos PubMed, EMBASE, Biblioteca Cochrane y Biblioteca Virtual de Salud. Para la selección de los estudios se consideraron los siguientes criterios: como población, personas mayores; como intervención, la prestación de atención transitoria después del alta hospitalaria; como comparador, la ausencia de atención transitoria después del alta hospitalaria; y como resultado, la eficacia del uso frente a la falta de uso de la atención transitoria, tomando como definición de eficacia la mejora de cualquier parámetro evaluado. Se incluyeron revisiones sistemáticas publicadas en español, inglés o portugués, con o sin metanálisis, en las cuales se evaluara la atención transitoria prestada a personas mayores después del alta hospitalaria y se excluyeron los estudios sin descripción de la intervención o del público destinatario correspondientes. Resultados. Se incluyeron 18 de las 207 revisiones halladas. Los estudios se habían realizado en 21 países (10 estudios en Europa y uno en Brasil). Se demostró la eficacia de la atención prestada a las personas mayores en cuanto a una mayor observancia de los tratamientos farmacológicos, una reducción del número de eventos adversos y errores en el uso de los medicamentos, una mejora del estado funcional de las personas mayores, una disminución de las caídas y un menor costo de la atención. Conclusiones. A pesar de haberse comprobado la eficacia de la atención transitoria, se necesitan nuevas investigaciones para elaborar indicadores más sólidos de la mejora clínica y de la integración en los sistemas de salud.
RESUMO
BACKGROUND: Preliminary evidence suggests statins may reduce major perioperative vascular events. However, evidence is limited to observational studies, underpowered trials, and non-comprehensive systematic reviews. This review aims to assess the effects of perioperative statin use on cardiovascular complications in patients submitted to non-cardiac surgery. METHODS: We will search MEDLINE/PubMed, EMBASE, LILACS, CENTRAL, Web of Science, and CINAHL for randomized controlled trials assessing the effects of perioperative statin use in adults undergoing non-cardiac surgery and reporting cardiovascular complications. For patients already using statins for hyperlipidemia, a preoperative loading dose of statin is required in the experimental group. We will place no language or publication restriction on our search. Teams of two reviewers will independently assess eligibility and risk of bias, and will extract data from the included trials. Our primary outcome is a combination of cardiovascular mortality or non-fatal myocardial infarction. We will also assess the following outcomes: individual components of the primary outcome, all-cause mortality, total myocardial infarction, elevated troponin in the first seven postoperative days, total stroke, total venous thromboembolism, postoperative atrial fibrillation, elevation of creatine phosphokinase or liver enzymes, and rates of myalgia or rhabdomyolysis. We will conduct meta-analyses using random-effects model and will use trial sequential analysis to establish monitoring boundaries to limit global type I error due to repetitive testing for our primary outcome. We will rate the quality of evidence using the GRADE system. DISCUSSION: The results of this systematic review may help to inform clinical practice and also the design of future large-scale randomized trials. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42016035987.
Assuntos
Inibidores de Hidroximetilglutaril-CoA Redutases , Infarto do Miocárdio/etiologia , Assistência Perioperatória/normas , Complicações Pós-Operatórias , Procedimentos Cirúrgicos Operatórios/efeitos adversos , Humanos , Inibidores de Hidroximetilglutaril-CoA Redutases/administração & dosagem , Inibidores de Hidroximetilglutaril-CoA Redutases/efeitos adversos , Mortalidade , Ensaios Clínicos Controlados Aleatórios como Assunto , Acidente Vascular Cerebral/etiologia , Revisões Sistemáticas como AssuntoRESUMO
INTRODUCTION: The use of vasoconstrictors combined with local anaesthetics (LAs) in dentistry for patients with cardiovascular disease (CVD) is still controversial in the scientific literature. It raises concerns regarding the possibility of transient episodes, triggering negative cardiovascular outcomes. METHOD/DESIGN: Trials eligible for our systematic review will enrol patients with CVD who have undergone dental treatments carried out with the use of LAs by comparing two arms: LAs with vasoconstrictors and LAs without vasoconstrictors. The research will be conducted in the electronic databases, namely Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, Embase, Healthstar (via Ovid), Cumulative Index to Nursing and Allied Health Literature and Web of Science, from their inception to December 2017, without any restrictions in terms of language and status of publication. A team of reviewers will independently assess titles, abstracts and complete text to determine eligibility. For eligible studies, the same reviewers will perform data extraction and evaluate the risk of bias in the selected articles. The selected outcomes comprise death, mortality by a specific cause, stroke, acute myocardial infarction, hospitalisation, pain, bleeding, arrhythmias, ischaemic episodes, anxiety, adverse effects, changes in blood pressure, changes in heart rate, anxiety and results obtained via oximetry. Whenever possible, we will conduct a meta-analysis to establish the effects of LAs with and without vasoconstrictors in the patients with CVD, and the overall quality of evidence for each outcome will be determined using the Grading of Recommendations Assessment, Development and Evaluation classification system. ETHICS AND DISSEMINATION: Ethics committee approval was not necessary because this is a protocol of systematic review. This systematic review will be submitted for presentation at conferences and for publication in a peer-reviewed journal. Our review will assess the risks of cardiovascular events when using LAs with and without vasoconstrictors in patients with CVD, focusing on important clinical outcomes. PROSPERO REGISTRATION NUMBER: CRD42016045421.
Assuntos
Anestesia Local/métodos , Anestésicos Locais/administração & dosagem , Doenças Cardiovasculares , Dentística Operatória/métodos , Vasoconstritores/efeitos adversos , Doenças Cardiovasculares/mortalidade , Humanos , Revisões Sistemáticas como AssuntoRESUMO
This study addresses the methodological trends in the development of systematic reviews in public health, and examines the reviews of the Cochrane Public Health Group in order to exemplify syntheses of evidence in public health and its implementation and impact on practice and research.
Assuntos
Prática Clínica Baseada em Evidências , Saúde Pública , Organização Mundial da SaúdeRESUMO
PURPOSE: To assess the effects of alveolar recruitment maneuvers (ARMs) on clinical outcomes in patients with acute respiratory distress syndrome (ARDS). METHODS: We conducted a search of the MEDLINE, EMBASE, LILACS, CINAHL, CENTRAL, Scopus, and Web of Science (from inception to July 2014) databases for all (i.e. no language restriction) randomized controlled trials (RCTs) evaluating the effects of ARMs versus no ARMs in adults with ARDS. Four teams of two reviewers independently assessed the eligibility of the studies identified during the search and appraised the risk of bias and extracted data from those which were assessed as meeting the inclusion criteria. Data were pooled using the random-effects model. Trial sequential analysis (TSA) was used to establish monitoring boundaries to limit global type I error due to repetitive testing for our primary outcome (in-hospital mortality). The GRADE system was used to rate the quality of evidence. RESULTS: Our database search identified ten RCTs (1,594 patients, 612 events) which satisfied the inclusion criteria. The meta-analysis assessing the effect of ARMs on in-hospital mortality showed a risk ratio (RR) of 0.84 [95 % confidence interval (CI) 0.74-0.95; I(2) = 0 %], although the quality of evidence was considered to be low due to the risk of bias in the included trials and the indirectness of the evidence--that is, ARMs were usually conducted together with other ventilatory interventions which may affect the outcome of interest. There were no differences in the rates of barotrauma (RR 1.11; 95 % CI 0.78-1.57; I(2) = 0 %) or need for rescue therapies (RR 0.76, 95 % CI 0.41-1.40; I(2) = 56 %). Most trials found no difference between groups in terms of duration of mechanical ventilation and length of stay in the intensive care unit and hospital. The TSA showed that the available evidence for the effect of ARMs on in-hospital mortality is precise in the case of a type I error of 5 %, but it is not precise with a type I error of 1 %. CONCLUSIONS: Although ARMs may decrease the mortality of patients with ARDS without increasing the risk for major adverse events, current evidence is not definitive. Large-scale ongoing trials addressing this question may provide data better applicable to clinical practice.
Assuntos
Síndrome do Desconforto Respiratório/terapia , Terapia Respiratória , Mortalidade Hospitalar , Humanos , Alvéolos Pulmonares , Resultado do TratamentoRESUMO
BACKGROUND: The impact of intravascular ultrasound (IVUS) use on stenting has shown inconclusive results. OBJECTIVE: Systematic review and meta-analysis of the impact of IVUS on stenting regarding the clinical and angiographic evolution. METHODS: A search was performed in Medline/Pubmed, CENTRAL, Embase, Lilacs, Scopus and Web of Science databases. It included randomized clinical trials (RCTs) that evaluated the implantation of stents guided by IVUS, compared with those using angiography alone (ANGIO). The minimum follow-up duration was six months and the following outcomes were assessed: thrombosis, mortality, myocardial infarction, percutaneous and surgical revascularization, major adverse cardiovascular events (MACE) and restenosis. The binary outcomes were presented considering the number of events in each group; the estimates were generated by a random effects model, considering Mantel-Haenszel statistics as weighting agent and magnitude of effect for the relative risk (RR) with its respective 95% confidence interval (95%CI). Higgins I² test was used to quantify the consistency between the results of each study. RESULTS: A total of 2,689 articles were evaluated, including 8 RCTs. There was a 27% reduction in angiographic restenosis (RR: 0.73, 95% CI: 0.54-0.97, I² = 51%) and statistically significant reduction in the rates of percutaneous revascularization and overall (RR: 0.88; 95% CI: 0.51 to 1.53, I² = 61%, RR: 0.73, 95% CI: 0.54 to 0.99, I² = 55%), with no statistical difference in surgical revascularization (RR: 0.95, 95% CI: 0.52-1.74, I² = 0%) in favor of IVUS vs. ANGIO. There were no differences regarding the other outcomes in the comparison between the two strategies. CONCLUSION: Angioplasty with stenting guided by IVUS decreases the rates of restenosis and revascularization, with no impact on MACE, acute myocardial infarction, mortality or thrombosis outcomes.
Assuntos
Angioplastia Coronária com Balão/métodos , Stents Farmacológicos , Ultrassonografia de Intervenção/métodos , Humanos , Implantação de Prótese/métodos , Ensaios Clínicos Controlados Aleatórios como Assunto , Reprodutibilidade dos Testes , Medição de Risco , Resultado do TratamentoRESUMO
Tight control of blood glucose reduces cardiovascular events and total mortality is conflicting. To summarize clinical effects of tight versus conventional glucose control in patients with type 2 diabetes. We systematically searched MEDLINE, EMBASE, Cochrane Library, and ISI Web of Knowledge with no limits of language and time. Further trials were searched from the reference lists of identified studies. We included randomized controlled comparing different levels of blood glucose control intensity in type 2 diabetic patients. Two independent reviewers extracted data of eligible studies using standard case report forms. We investigated total mortality, cardiovascular and microvascular events, and hypoglycemia in patients with type 2 diabetes. We used random-effects models to obtain relative risks (RR) with 95% confidence intervals (CI). We included 6 trials involving 27,654 patients. There was no significant effect of tight blood glucose control on all-cause mortality (RR 1.03; 95% CI 0.90-1.17) or cardiovascular mortality (RR 1.04; 95% CI 0.83-1.29). Tight glucose control reduced the risk for nonfatal MI (RR 0.85; 95% CI 0.76-0.95), although had no effect on the incidence of nonfatal stroke (RR 1.02; 95% CI 0.88-1.17). For microvascular events, tight glucose control reduced the risk progression of retinopathy (RR 0.80; 95% CI 0.71-0.91), incidence of peripheral neuropathy (RR 0.94; 95% CI 0.89-0.99), and progression of nephropathy (RR 0.55; 95% CI 0.37-0.80), but had not significant effect on the incidence of nephropathy (RR 0.69; 95% CI 0.42-1.14). The risk of severe hypoglycemia increased with tight glucose control (RR 2.39; 95% CI 1.79-3.18). Tight blood glucose control reduces the risk for some macrovascular and microvascular events, without effect on all-cause mortality and cardiovascular mortality. Tight glucose control increases the risk of severe hypoglycemia.
Assuntos
Glicemia/análise , Diabetes Mellitus Tipo 2/terapia , Idoso , Doenças Cardiovasculares/mortalidade , Diabetes Mellitus Tipo 2/sangue , Diabetes Mellitus Tipo 2/mortalidade , Feminino , Hemoglobinas Glicadas/análise , Humanos , Masculino , Pessoa de Meia-Idade , Ensaios Clínicos Controlados Aleatórios como AssuntoRESUMO
FUNDAMENTO: O impacto do uso do ultrassom intracoronariano (USIC) na implantação de stents tem resultados inconclusivos. OBJETIVO: Revisão sistemática, com metanálise, do impacto do USIC na implantação de stents quanto à evolução clínica e angiográfica. MÉTODOS: Efetuada busca nas bases Medline/Pubmed, CENTRAL, Embase, Lilacs, Scopus e Web of Science. Incluídos estudos clínicos randomizados (ECR) que avaliaram o implante de stents, orientados pela USIC, comparados com aqueles utilizando a angiografia isoladamente (ANGIO). O intervalo mínimo de acompanhamento foi de seis meses, avaliados os desfechos: trombose, mortalidade, infarto do miocárdio, revascularização percutânea e cirúrgica, eventos cardiovasculares maiores (ECVM) e reestenose. Os desfechos binários foram apresentados considerando o número de eventos em cada grupo; as estimativas foram geradas por um modelo de efeitos aleatórios, considerando a estatística de Mantel-Haenzel como ponderadora e magnitude de efeito ao risco relativo (RR) com seu respectivo intervalo de confiança de 95% (IC 95%). Para quantificação da consistência entre os resultados de cada estudo, utilizou-se o teste de inconsistência I² de Higgins. RESULTADOS: Avaliados 2.689 artigos, incluídos 8 ECR. Houve redução de 27% na reestenose angiográfica (RR: 0,73; IC 95%: 0,54 - 0,97; I² = 51%) e redução estatisticamente significativa nas taxas de revascularizações percutânea e geral (RR: 0,88; IC 95%: 0,51 - 1,53; I² = 61% e RR: 0,73; IC 95%: 0,54 - 0,99; I² = 55%), sem diferença estatística na revascularização cirúrgica (RR: 0,95; IC 95%: 0,52 - 1,74; I² = 0%) em favor do USIC vs. ANGIO. Não foram observadas diferenças nos demais desfechos na comparação entre as duas estratégias. CONCLUSÃO: Angioplastias com implante de stents guiadas por USIC reduzem taxas de reestenose e de revascularizações, não tendo impacto nos desfechos ECVM, infarto agudo do miocárdio, mortalidade ou trombose.
BACKGROUND: The impact of intravascular ultrasound (IVUS) use on stenting has shown inconclusive results. OBJECTIVE: Systematic review and meta-analysis of the impact of IVUS on stenting regarding the clinical and angiographic evolution. METHODS: A search was performed in Medline/Pubmed, CENTRAL, Embase, Lilacs, Scopus and Web of Science databases. It included randomized clinical trials (RCTs) that evaluated the implantation of stents guided by IVUS, compared with those using angiography alone (ANGIO). The minimum follow-up duration was six months and the following outcomes were assessed: thrombosis, mortality, myocardial infarction, percutaneous and surgical revascularization, major adverse cardiovascular events (MACE) and restenosis. The binary outcomes were presented considering the number of events in each group; the estimates were generated by a random effects model, considering Mantel-Haenszel statistics as weighting agent and magnitude of effect for the relative risk (RR) with its respective 95% confidence interval (95%CI). Higgins I² test was used to quantify the consistency between the results of each study. RESULTS: A total of 2,689 articles were evaluated, including 8 RCTs. There was a 27% reduction in angiographic restenosis (RR: 0.73, 95% CI: 0.54-0.97, I² = 51%) and statistically significant reduction in the rates of percutaneous revascularization and overall (RR: 0.88; 95% CI: 0.51 to 1.53, I² = 61%, RR: 0.73, 95% CI: 0.54 to 0.99, I² = 55%), with no statistical difference in surgical revascularization (RR: 0.95, 95% CI: 0.52-1.74, I² = 0%) in favor of IVUS vs. ANGIO. There were no differences regarding the other outcomes in the comparison between the two strategies. CONCLUSION: Angioplasty with stenting guided by IVUS decreases the rates of restenosis and revascularization, with no impact on MACE, acute myocardial infarction, mortality or thrombosis outcomes.